08:00 , Mar 21, 2005 |  BC Week In Review  |  Clinical News

Cobas AmpliScreen HCV test and Cobas AmpliScreen HIV-1 test regulatory update

FDA approved Cobas AmpliScreen HCV and Cobas AmpliScreen HIV-1 tests to screen blood samples from cadaveric organ and tissue donations. The PCR-based nucleic acid tests (NATs) are approved for screening whole blood, source plasma and...
08:00 , Jan 6, 2003 |  BC Week In Review  |  Clinical News

COBAS AmpliScreen tests regulatory update

The FDA cleared ROCZ's COBAS AmpliScreen HCV Test version 2.0 and the COBAS AmpliScreen HIV-1 Test version 1.5 for blood screening. The company also received FDA clearance for the COBAS AmpliScreen Data Output Management System...
07:00 , Apr 15, 2002 |  BC Week In Review  |  Clinical News

COBAS AmpliScreen HIV-1 test regulatory update

Italy granted marketing clearance to ROCZ’s Roche Diagnostics division for its COBAS AmpliScreen HIV-1 PCR-based HIV blood test. Roche (SWX:ROCZ), Basel, Switzerland   Product: COBAS AmpliScreen HIV-1 test , version 1.5   Business: Supply/Service  ...